STENOCARE deadlines for its ongoing Unit Right Issue: Last day for subscription for shares at DKK 4
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

Pressmeddelande

STENOCARE deadlines for its ongoing Unit Right Issue: Last day for subscription for shares at DKK 4.58 each is Thursday June 8

STENOCARE A/S
NASDAQ FIRST NORTH GROWTH MARKET, DENMARK

TICKER:  STENO

STENOCARE A/S (“Stenocare”) is currently offering its shareholders and new investors to join its public issue with a formal last day on Thursday, June 8, 2023. investors should be aware that Nordnet has defined Tuesday June 6 as the deadline to subscribe in their system.

Note: Monday, June 5, 2023 is a bank holiday in Denmark (Grundlovsdag), and Tuesday June 6 is a bank holiday in Sweden (Nationaldag). Nordnet is open for online subscription both days.

Clarification and recommendation to act now: Stenocare provides this clarification in response to several questions received about the last day of subscription. The last day at which the issuing bank (Danske Bank) must receive any subscriptions – with or without rights - is Thursday, June 8, 2023, but certain banks – such as Nordnet – have decided to reserve some time for their expedition of customer orders to Danske Bank. Customers of Danske Bank can submit their subscriptions from clients all the way to June 8, 2023, but all interested subscribers must subscribe asap and follow the instructions and deadlines of their own banks.

Last day of trading in rights: In any case, the formal deadline for purchase of unit rights – which is the instrument that can be purchased by anyone that does not have (enough) rights from an existing holding of shares – is June 6, 2023. Also, subscription can be made without the backing of rights. This is done digitally through Nordnet/Avanza or by filling in and sending the special form for subscription without rights to the bank: https://stenocare.com/wp-content/uploads/2023/05/SUBSCRIPTION-FORM-without-use-of-Unit-Rights-ENG-.pdf

About the issue: The ongoing public share issue is for Units, at a price per unit of DKK 9.16, including 2 shares (at DKK 4.58 each) and 2 free warrants. The unit rights issue amounts to up to 10,7mDKK and is backed by pre-subscription from management, board and others, as well as guarantors, amounting to a total of 86% of the issue and lenders that have committed to convert into Units. In total, this corresponds to more than 100% of the issue, but in order to make room for public subscription if needed, the conversion of debt will take place in a separate directed issue, in addition to the public issue. Links:

https://www.nordnet.dk/dk/kampagner/emission/stenocare

https://stenocare.com/share-issue-2023/

Minimum requirement: Please notice that according to Nasdaq policy there is a minimum subscription of Euro 500 for investors without Unit Rights – which is approx. equal to 407 Units. However, investors that like to subscribe for less than 407 Units can purchase Unit Rights for the desired number of Units (for each Unit the investor need to purchase 10 Unit Rights). The price of a Unit Right (ticker: “STENO UR”) is available from the bank or from Nasdaq STENO UR, Stenocare A/S UR, (DK0062493458) - Nasdaq (nasdaqomxnordic.com)

Bifogade filer

STENOCARE - deadlines for investorshttps://mb.cision.com/Main/17551/3780343/2105124.pdf

Nyheter om Stenocare

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!

STÄNG X
Populär sparapp – över 500 000 nedladdningar
Många och höga externa omdömen
Högst grad av diversifiering
Perfekt för regelbundet månadssparande
KOM IGÅNG

Nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 får automatiskt 50 procent rabatt på Optis avgift i 3 månader

Om aktien Stenocare

Senaste nytt